Message From CEO Gonzalez

Quote

Anonymous

Guest
Today is our first day as an independent, global biopharmaceutical company. I’ve recorded a video greeting to all of our colleagues for this very special occasion you.

It’s an exciting time for AbbVie and all of us. Tomorrow, on January 2, I will be joined by our leadership team and some 100 of our colleagues from around the world on the floor of the New York Stock Exchange, where we will ring the bell to begin the first day of trading for 2013 – and the first day of trading for the stock of our new company.

The bell ringing will be broadcast live on the CNBC network at 9:30 a.m., EST.
Because a truly global company like ours crosses multiple time zones, and because of planned New Years’ holidays, I realize many of our colleagues won’t be able to see Wednesday’s ceremonies live. We’ll have a full replay of all the events available on the new Our AbbVie employee intranet soon after the events take place.

I look forward to sharing more details about our new company with you soon. For now, I hope you share in my excitement at the task ahead of us – creating a new biopharmaceutical company that will continue to advance our purpose of having a remarkable impact on the lives of millions of people around the world.
Best regards,

Rick
 

I have: no faith, no trust, no intention to exert any effort to help Ricky and his co-conspirators succeed at ripping off the stockholders. I'll be moving my thousands of Abbott shares to other investments. This train is crashing.
 
Who spelled "biopharmaceutical" for you, Ricky? You're presence is the biggest factor favoring failure of AbbVie. There's nothing like going to sea with a broken engine, a leaky boat, a mutinous crew, and rotten strawberries is there, Captain Queeg?
 
Anonymous said:
I have: no faith, no trust, no intention to exert any effort to help Ricky and his co-conspirators succeed at ripping off the stockholders. I'll be moving my thousands of Abbott shares to other investments. This train is crashing.
Click to expand...

Fore sure, in Europe Hospira (also being a part of Abbott in the past) will launch the first TNF-ab biosimilar (well of Southkorean origin like Samsung) in the next weeks - even with more indications HUMIRA will crash due to the financial crisis, Pfizers oral product will do the rest.
 


Write your reply...
Top Bottom
Back
Quote